<DOC>
	<DOCNO>NCT02229786</DOCNO>
	<brief_summary>Study evaluate efficacy tolerability Buscopan® plus versus Buscopan® , paracetamol , placebo patient painful gastric intestinal spasm .</brief_summary>
	<brief_title>Efficacy Tolerability Buscopan Plus Painful Gastric Intestinal Spasms</brief_title>
	<detailed_description />
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Butylscopolammonium Bromide</mesh_term>
	<mesh_term>Scopolamine Hydrobromide</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Male female patient Age : 18 70 year Diagnosis : recur painful gastric intestinal spasm occur e.g . irritable bowel syndrome , organic origin , present least 2 month , serious enough interfere everyday activity Patient brief per §§ 40/41 Arzneimittelgesetz ( AMG ) patient 's declaration Informed Consent writing , agreement Good Clinical Practice ( GCP ) current legal requirement A pain assessment 3 cm visual analog scale least one 2 day immediately precede second visit Painful gastric intestinal spasm organic origin Crohn 's disease , ulcerative colitis , lactose intolerance Tumour pain/malignant growth Patients severe pain state organic origin ( e.g . biliary colic ) Mechanical stenoses gastrointestinal tract , megacolon Urinary retention associate mechanical stenosis urinary tract ( e.g . prostate adenoma ) Narrowangle glaucoma Tachyarrhythmia Myasthenia gravis Glucose 6phosphate dehydrogenase deficiency ( danger haemolytic anaemia ) Known hypersensitivity Nbutylscopolammonium bromide paracetamol Severe liver impairment ( e.g . chronic alcohol abuse , hepatitis ) : ) SerumGlutamateOxalacetatTransaminase/ Aspartate Aminotransferase ( SGOT ) high four time norm b ) Bilirubin &gt; 3 mg/dl c ) Quick 's value &lt; 70 % MeulengrachtGilbert syndrome ( metabolic disturbance episode jaundice ) Severe kidney failure : creatinine &gt; 2 mg/dl Known depression know mental illness , anxiety disturbance Concomitant intake analgesic , nonsteroidal antiinflammatory drug ( NSAIDs ) and/or spasmolytic , anticholinergic , nitrate Concomitant medication affect gastrointestinal motility Regular ( daily ) use laxatives Drugs induce liver enzymes Concomitant administration chloramphenicol Use narcotic Antidepressant treatment treatment psychoactive drug Pregnancy lactation Alcohol abuse ( 60 g alcohol/day ) Frequent vomit might prevent adequate absorption active ingredient filmcoated tablet take Patients unlikely able keep examination appointment reliably take study medication regularly Simultaneous participation another clinical study Patients train VAS ( PI ) Visit 1</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>